Quince Therapeutics (QNCX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Quince Therapeutics (QNCX) Company Statistics | The Fly

Quince Therapeutics

· QNCX

Dashboard

Financials

Ratios

Valuation

Statistics

31.702 M

-0.51%

General

Market Cap: $31.7M
Enterprise Value: -$107.35M
Shares Outstanding: 980,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -74.58%
ROE: -413.28%
ROIC: -104.64%
Current Ratio: 14.52
Debt-to-Equity: —
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 0.08
EV/EBITDA: 1.48

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $123.64M
Operating Income: -$123.68M
Net Profit: -$92.48M

Balance Sheet

Cash and Equivalents: $115.98M
Working Capital: $114.91M
Total Assets: $124M
Net Debt: -$115.98M
Total Liabilities: $15.51M
Total Equity: $108.49M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$46.92M
Cash Flow from Investing: $26.29M
Cash Flow from Financing: $121.79M
Free Cash Flow: -$47M
Capital Expenditures: $78K